Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Prachi Saini
L. Lakshmayya
Vinod Singh Bisht
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.
Year: 2017 | Doi: 10.4103/ayu.AYU_174_16
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Aim: The aim of this study is to find out the anti-Alzheimer’s activity of isolated karanjin and embelin.
Other Science Concepts:
Discover the significance of concepts within the article: �Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.�. Further sources in the context of Science might help you critically compare this page with similair documents:
Embelia ribes, Pongamia pinnata, Memory retention, Statistical analysis, Thin Layer Chromatography, Neuroprotective activity, Learning and memory, Oxidative stress, Elevated Plus Maze, Anxiety and depression, Swiss albino mice, Vehicle control, Dose-dependent manner, Anti-Alzheimer's activity, Morris water maze, Diazepam-induced amnesia, Plant material extraction, Amnesia, Ethnobotanical use, Cognitive symptoms, Cholinergic deficit, Neurodegenerative disease, N-methyl D-aspartate receptor antagonist, Cholinesterase inhibitor.